The investment is expected to raise the Halol site’s current annual capacity from 110,000 units to 300,000 units.
A Sun Pharmaceutical plant that has been a problem for the FDA, and so for the Indian drugmaker, is again having to recall a product that the company said failed dissolution testing. According to the ...
JSW MG Motor’s upcoming midsize SUV, expected to be called MG Starlight 560, has now been spied in India for the first time ...
After years of criticism from the FDA, Sun’s Halol plant still can’t get through an FDA inspection without the agency finding some deficiency. In June, it was just one observation, but a just ...
A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations. In the letter to Mumbai-based company, the USFDA pointed out drug firm's ...
In July 2015, General Motors announced that it will shutter its Halol plant in India as a result of a decision to consolidate vehicle production operations at its plant in the city of Talegaon. At the ...
MUMBAI – The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results